| Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners (NCT02596490) | M.D. Anderson Cancer Center | 2016-04-06 |
| Lenalidomide and Obinutuzumab in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT02225275) | M.D. Anderson Cancer Center | 2016-03-31 |
| Houston Independent School District (HISD) Yoga Evaluation (NCT02606591) | M.D. Anderson Cancer Center | 2016-03-31 |
| Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer (NCT02626130) | M.D. Anderson Cancer Center | 2016-03-30 |
| Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib (NCT02636322) | M.D. Anderson Cancer Center | 2016-03-29 |
| Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS) (NCT02599649) | M.D. Anderson Cancer Center | 2016-03-21 |
| EBUS TBNA After PET/CT in Diagnosing Patients With Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation Therapy (NCT02719847) | M.D. Anderson Cancer Center | 2016-03-18 |
| Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia (NCT02629809) | M.D. Anderson Cancer Center | 2016-03-18 |
| SINF: Peripheral Neuropathy in Cancer Survivors (NCT02168894) | M.D. Anderson Cancer Center | 2016-03-01 |
| Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) (NCT02473042) | M.D. Anderson Cancer Center | 2016-03-01 |
| Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy (NCT05049746) | M.D. Anderson Cancer Center | 2016-02-23 |
| Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia (NCT02689440) | M.D. Anderson Cancer Center | 2016-02-19 |
| Evaluation of Satisfaction With Quality of Care on the Palliative Care Unit (NCT02686411) | M.D. Anderson Cancer Center | 2016-02-17 |
| Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function (NCT02626312) | M.D. Anderson Cancer Center | 2016-02-15 |
| Autologous Fat Grafting Techniques in Patients Undergoing Reconstructive Surgery (NCT02677012) | M.D. Anderson Cancer Center | 2016-02-04 |
| Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer (NCT02530489) | M.D. Anderson Cancer Center | 2016-02-04 |
| Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02659241) | M.D. Anderson Cancer Center | 2016-02-04 |
| Neoadjuvant and Adjuvant Checkpoint Blockade (NCT02519322) | M.D. Anderson Cancer Center | 2016-02-02 |
| Sublingual Fentanyl for the Management of Breakthrough Pain (NCT02514252) | M.D. Anderson Cancer Center | 2016-02-02 |
| Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy (NCT02662907) | M.D. Anderson Cancer Center | 2016-02-01 |
| MPDL3280A With Chemoradiation for Lung Cancer (NCT02525757) | M.D. Anderson Cancer Center | 2016-01-26 |
| Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking (NCT02224391) | M.D. Anderson Cancer Center | 2016-01-20 |
| Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative (NCT02456857) | M.D. Anderson Cancer Center | 2016-01-12 |
| Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines (NCT02408432) | M.D. Anderson Cancer Center | 2016-01-11 |
| A Smoking Prevention Program (ASPIRE) and Mentoring for Preventing Smoking Among High School Youths (NCT04803682) | M.D. Anderson Cancer Center | 2016-01-08 |
| Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea (NCT02597478) | M.D. Anderson Cancer Center | 2016-01-04 |
| Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell (NCT02663583) | M.D. Anderson Cancer Center | 2016-01-01 |
| Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery (NCT02520141) | M.D. Anderson Cancer Center | 2015-12-29 |
| An Investigational Device (Millar Mikro-Tip Catheter) and Imaging Scan (Shear Wave Elastography) in Measuring Tumor Pressure and Stiffness in Patients With Solid Tumors Undergoing Ultrasound-Guided Biopsy (NCT04054154) | M.D. Anderson Cancer Center | 2015-12-29 |
| Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC) (NCT02662608) | M.D. Anderson Cancer Center | 2015-12-29 |
| Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors (NCT02426892) | M.D. Anderson Cancer Center | 2015-12-23 |
| Safety Evaluation of Intra-Operative MRI-Based Guidance for Laser Ablation of Epidural Metastasis (NCT02613390) | M.D. Anderson Cancer Center | 2015-12-18 |
| Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia (NCT02530515) | M.D. Anderson Cancer Center | 2015-12-18 |
| CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies (NCT02529813) | M.D. Anderson Cancer Center | 2015-12-16 |
| Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma (NCT02726750) | M.D. Anderson Cancer Center | 2015-12-14 |
| Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma (NCT02392039) | M.D. Anderson Cancer Center | 2015-12-14 |
| Reward Sensitivity and Pharmacotherapy for Smoking Cessation (NCT02162849) | M.D. Anderson Cancer Center | 2015-12-14 |
| Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia (NCT02530476) | M.D. Anderson Cancer Center | 2015-12-08 |
| Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication (NCT02511600) | M.D. Anderson Cancer Center | 2015-12-01 |
| A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT02532192) | M.D. Anderson Cancer Center | 2015-12-01 |
| Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors (NCT03039439) | M.D. Anderson Cancer Center | 2015-11-24 |
| Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy (NCT02615275) | M.D. Anderson Cancer Center | 2015-11-24 |
| Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer (NCT02592356) | M.D. Anderson Cancer Center | 2015-11-16 |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT02419469) | M.D. Anderson Cancer Center | 2015-11-13 |
| Occupational Therapy in Palliative Care (NCT02521194) | M.D. Anderson Cancer Center | 2015-11-13 |
| Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer (NCT02394535) | M.D. Anderson Cancer Center | 2015-11-12 |
| Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative (NCT02276443) | M.D. Anderson Cancer Center | 2015-11-09 |
| Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients (NCT03048266) | M.D. Anderson Cancer Center | 2015-11-05 |
| A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma (NCT02529852) | M.D. Anderson Cancer Center | 2015-11-04 |
| Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT02420795) | M.D. Anderson Cancer Center | 2015-11-03 |
| ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome (NCT02392572) | M.D. Anderson Cancer Center | 2015-11-03 |
| Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers (NCT02596711) | M.D. Anderson Cancer Center | 2015-11-02 |
| Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer (NCT02590458) | M.D. Anderson Cancer Center | 2015-10-26 |
| Nivolumab in AML in Remission at High Risk for Relapse (NCT02532231) | M.D. Anderson Cancer Center | 2015-10-19 |
| Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT02405078) | M.D. Anderson Cancer Center | 2015-10-13 |
| Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior (NCT03046524) | M.D. Anderson Cancer Center | 2015-10-06 |
| Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure (NCT02464696) | M.D. Anderson Cancer Center | 2015-10-06 |
| Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma (NCT02420613) | M.D. Anderson Cancer Center | 2015-10-05 |
| Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors (NCT02389309) | M.D. Anderson Cancer Center | 2015-10-05 |
| Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix (NCT02206048) | M.D. Anderson Cancer Center | 2015-10-02 |
| Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy (NCT02573766) | M.D. Anderson Cancer Center | 2015-10-01 |
| Studying Changes in Physical Function Measures in Stem Cell Transplant Patients at Risk for Steroid Myopathy (NCT04521777) | M.D. Anderson Cancer Center | 2015-10-01 |
| Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With Sarcoma (NCT05216029) | M.D. Anderson Cancer Center | 2015-10-01 |
| Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer (NCT02360059) | M.D. Anderson Cancer Center | 2015-10-01 |
| Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS) (NCT02469415) | M.D. Anderson Cancer Center | 2015-09-30 |
| Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center (NCT02502396) | M.D. Anderson Cancer Center | 2015-09-28 |
| Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia (NCT02420665) | M.D. Anderson Cancer Center | 2015-09-23 |
| Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis (NCT02385110) | M.D. Anderson Cancer Center | 2015-09-23 |
| An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors (NCT04993261) | M.D. Anderson Cancer Center | 2015-09-23 |
| Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer (NCT02397083) | M.D. Anderson Cancer Center | 2015-09-23 |
| Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer (NCT02444741) | M.D. Anderson Cancer Center | 2015-09-17 |
| Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease (NCT02458014) | M.D. Anderson Cancer Center | 2015-09-14 |
| Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) (NCT02441803) | M.D. Anderson Cancer Center | 2015-09-14 |
| Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain (NCT02459964) | M.D. Anderson Cancer Center | 2015-09-14 |
| Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma (NCT02506959) | M.D. Anderson Cancer Center | 2015-09-14 |
| Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome (NCT02530463) | M.D. Anderson Cancer Center | 2015-09-08 |
| Video Double-Lumen Tube Prospective Randomized Study (NCT02429414) | M.D. Anderson Cancer Center | 2015-09-01 |
| Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma (NCT04778449) | M.D. Anderson Cancer Center | 2015-08-26 |
| Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin (NCT02420691) | M.D. Anderson Cancer Center | 2015-08-25 |
| Perception of Palliative Care Encounter (NCT02558257) | M.D. Anderson Cancer Center | 2015-08-16 |
| Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer (NCT02491632) | M.D. Anderson Cancer Center | 2015-08-13 |
| Edmonton Symptom Assessment Scale: Self-Completion vs. Assisted-Completion (NCT02523378) | M.D. Anderson Cancer Center | 2015-08-13 |
| Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma (NCT02500576) | M.D. Anderson Cancer Center | 2015-08-07 |
| Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma (NCT02446457) | M.D. Anderson Cancer Center | 2015-07-31 |
| Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention (NCT02423915) | M.D. Anderson Cancer Center | 2015-07-30 |
| Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus (NCT02479698) | M.D. Anderson Cancer Center | 2015-07-23 |
| Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer (NCT02402920) | M.D. Anderson Cancer Center | 2015-07-22 |
| Registry Study for Personalized Cancer Therapy (NCT02508662) | M.D. Anderson Cancer Center | 2015-07-21 |
| Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia (NCT02420717) | M.D. Anderson Cancer Center | 2015-07-15 |
| Intratumoral Injections of LL37 for Melanoma (NCT02225366) | M.D. Anderson Cancer Center | 2015-07-08 |
| Robotic Harvest of the Latissimus Dorsi (LD) Muscles (NCT02274493) | M.D. Anderson Cancer Center | 2015-07-08 |
| Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma (NCT02494700) | M.D. Anderson Cancer Center | 2015-07-06 |
| Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery (NCT02420847) | M.D. Anderson Cancer Center | 2015-07-03 |
| Patients Navigators in Facilitating Weight Management in Obese Participants (NCT03674229) | M.D. Anderson Cancer Center | 2015-07-02 |
| Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) (NCT02464657) | M.D. Anderson Cancer Center | 2015-07-01 |
| EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors (NCT01591356) | M.D. Anderson Cancer Center | 2015-07-01 |
| The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant Setting (NCT02271906) | M.D. Anderson Cancer Center | 2015-07-01 |
| Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer Patients (NCT02321527) | M.D. Anderson Cancer Center | 2015-07-01 |
| Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion (NCT02498899) | M.D. Anderson Cancer Center | 2015-07-01 |
| Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients (NCT02420938) | M.D. Anderson Cancer Center | 2015-07-01 |